How much funding has Causaly raised?

Causaly has raised $78.0M in total funding, most recently a Series B round.

Who are Causaly's investors?

Causaly's investors include Index Ventures, ICONIQ Capital, Marathon Venture Partners, Pentech, EBRD Venture Capital.

Where is Causaly headquartered?

Causaly is headquartered in London, United Kingdom.

What industry is Causaly in?

Causaly operates in Artificial Intelligence, Biotech.

Causaly

The Most Complete AI Platform For Life Sciences

London, United Kingdom · Founded 2018 · $78.0M raised

Artificial Intelligence

Biotech

Headquarters: London
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: causaly.com
Total Funding: $78.0M
Last Round: $60.0M Series BJul 2023
Rounds: 3

About

Founded in 2018, Causaly provides the leading production-grade generative AI platform for life sciences R&D. Its platform combines a high-precision biomedical knowledge graph, a generative AI copilot, enterprise data fabric, and scientific RAG (retrieval-augmented generation) to help researchers at pharmaceutical and biotech companies find, analyze, and synthesize evidence across millions of scientific publications and internal datasets. Causaly's agentic AI automates research workflows for target identification, biomarker discovery, drug safety analysis, and clinical development, enabling scientists to make faster, evidence-backed decisions.

Summary

Causaly is an Artificial Intelligence company based in London, United Kingdom, founded in 2018. It has raised $78.0M in total across 3 rounds, most recently a $60.0M Series B round in Jul 2023. Investors include Index Ventures, ICONIQ Capital and Marathon Venture Partners.